Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04879017
Title FHD-286 in Subjects With Metastatic Uveal Melanoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Foghorn Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | FRA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
University of Miami Health System, Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University, Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Sidney Kimmel Cancer Center - Jefferson Health Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37205 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Institute Curie Hospital Paris France Details
Leiden University Medical Center Leiden Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field